Page last updated: 2024-12-06

uridine diphosphate xylose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Uridine Diphosphate Xylose: The decarboxylation product of UDPglucuronic acid, which is used for formation of the xylosides of seryl hydroxyl groups in mucoprotein synthesis. Also forms plant xylans. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID19235
CHEBI ID16082
MeSH IDM0022355

Synonyms (26)

Synonym
uridine diphosphate xylose
uridine 5'-[3-(alpha-d-xylopyranosyl) dihydrogen diphosphate]
CHEBI:16082
udpxylose
uridine 5'-(trihydrogen diphosphate), p'-alpha-d-xylopyranosyl ester
mono-a-d-xylopyranosyl ester
uridine 51-pyrophosphate, a-d-xylopyranosyl ester
uridine-5'-diphosphate-xylopyranose
udp xylose
udx ,
p1-a-d-xylopyranosyl ester
DB01713
[[(2r,3s,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl] hydrogen phosphate
unii-i839tb018f
gtpl4730
{[(2r,3s,4r,5r)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[hydroxy({[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy})phosphoryl]oxy})phosphinic acid
J-700264
udp-a-d-xylose
AC-33209
udp-alpha
alpha-d-xylopyranosyl ester
alpha-delta-xylopyranosyl ester
udp-delta-xylose
[(2r,3s,4r,5r)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2r,3r,4s,5r)-3,4,5-trihydroxytetrahydro-2h-pyran-2-yl dihydrogen diphosphate (non-preferred name)
Q27089069
DTXSID70863225
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
fundamental metaboliteAny metabolite produced by all living cells.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
UDP-sugarA pyrimidine nucleotide-sugar having UDP as the nucleotide component attached to an unspecified sugar via an anomeric diphosphate linkage.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Proteoglycan biosynthesis011
UDP-L-arabinose biosynthesis I from UDP-xylose02

Research

Studies (102)

TimeframeStudies, This Drug (%)All Drugs %
pre-199035 (34.31)18.7374
1990's15 (14.71)18.2507
2000's24 (23.53)29.6817
2010's24 (23.53)24.3611
2020's4 (3.92)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.87 (24.57)
Research Supply Index4.66 (2.92)
Research Growth Index4.53 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.95%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other104 (99.05%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]